The effect of IC87114 on the activity of several protein kinases and a phosphatase
| Enzyme . | Activity (% of control) ± SD . | 
|---|---|
| EGF receptor tyrosine kinase | 102 ± 5.5 | 
| Insulin receptor tyrosine kinase | 98 ± 6.2 | 
| CD45 tyrosine phosphatase | 104 ± 2.2 | 
| PKC-θ | 97 ± 5.5 | 
| PDK1 | 91.5 ± 2.1 | 
| Lck | 116.5 ± 9.2 | 
| P70S6K | 98.5 ± 0.7 | 
| CDK2/cyclinA | 92.5 ± 2.12 | 
| ZAP-70 | 97.5 ± 13.4 | 
| p38 MAPK | No inhibition* | 
| DNA-PK | No inhibition* | 
| CHK1 | No inhibition* | 
| cSrc | No inhibition* | 
| CK1 | No inhibition* | 
| PKBα (Akt 1) | No inhibition* | 
| PKCα | No inhibition* | 
| PKCβII | No inhibition* | 
| Enzyme . | Activity (% of control) ± SD . | 
|---|---|
| EGF receptor tyrosine kinase | 102 ± 5.5 | 
| Insulin receptor tyrosine kinase | 98 ± 6.2 | 
| CD45 tyrosine phosphatase | 104 ± 2.2 | 
| PKC-θ | 97 ± 5.5 | 
| PDK1 | 91.5 ± 2.1 | 
| Lck | 116.5 ± 9.2 | 
| P70S6K | 98.5 ± 0.7 | 
| CDK2/cyclinA | 92.5 ± 2.12 | 
| ZAP-70 | 97.5 ± 13.4 | 
| p38 MAPK | No inhibition* | 
| DNA-PK | No inhibition* | 
| CHK1 | No inhibition* | 
| cSrc | No inhibition* | 
| CK1 | No inhibition* | 
| PKBα (Akt 1) | No inhibition* | 
| PKCα | No inhibition* | 
| PKCβII | No inhibition* | 
The selectivity of IC87114 (10 μM) was tested against several human protein kinases and a phosphatase. Protein kinase assays were performed in the presence of 100 μMATP.
EGF indicates epidermal growth factor; PKC, protein kinase C; PKB, protein kinase B; PK, protein kinase; CHK1, checkpoint kinase 1; and CK, casein kinase-1.
Sadhu et al.24